Literature DB >> 12498284

Assessment of fatigue in patients with chronic hepatitis C using the Fatigue Impact Scale.

Ziad Hassoun1, Bernard Willems, Julie Deslauriers, Bich Ngoc Nguyen, Pierre-Michel Huet.   

Abstract

The aim of this study was to assess the impact of fatigue on the quality of life of patients with chronic hepatitis C (CHC) and to examine its relationship with various parameters of the disease, including viral load. The Fatigue Impact Scale (FIS), a self-report questionnaire, was applied to 92 patients with CHC, and the results were compared to those of an age-matched cohort of 213 healthy blood donors. Fatigue was frequent and disabling, being present in 67% of CHC patients, and the FIS was significantly increased in CHC patients compared to the healthy controls. Fatigue severity was not correlated with the activity of the disease or with the level of viremia. The FIS proved to be a valuable tool to assess this symptom. It should be of help for better evaluation of the clinical spectrum of the disease and should be included in trials assessing the efficacy of therapeutic interventions.

Entities:  

Mesh:

Year:  2002        PMID: 12498284     DOI: 10.1023/a:1021040702370

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group.

Authors:  H L Bonkovsky; J M Woolley
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

2.  Health assessment for chronic HCV infection: results of quality of life.

Authors:  R L Carithers; D Sugano; M Bayliss
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

3.  Impact of fatigue on the quality of life of patients with primary biliary cirrhosis.

Authors:  P M Huet; J Deslauriers; A Tran; C Faucher; J Charbonneau
Journal:  Am J Gastroenterol       Date:  2000-03       Impact factor: 10.864

4.  Musculoskeletal pain and fatigue are associated with chronic hepatitis C: a report of 239 hepatology clinic patients.

Authors:  A Barkhuizen; H R Rosen; S Wolf; K Flora; K Benner; R M Bennett
Journal:  Am J Gastroenterol       Date:  1999-05       Impact factor: 10.864

5.  Sustained virologic response is associated with improved health-related quality of life in relapsed chronic hepatitis C patients.

Authors:  M P Neary; S Cort; M S Bayliss; J E Ware
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

6.  Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium.

Authors: 
Journal:  J Viral Hepat       Date:  1999-01       Impact factor: 3.728

7.  Clinical, biochemical and histological features in 102 patients with chronic hepatitis C virus infection.

Authors:  I Merican; S Sherlock; N McIntyre; G M Dusheiko
Journal:  Q J Med       Date:  1993-02

8.  Depression, fatigue, and functional disability in patients with chronic hepatitis C.

Authors:  M M Dwight; K V Kowdley; J E Russo; P S Ciechanowski; A M Larson; W J Katon
Journal:  J Psychosom Res       Date:  2000-11       Impact factor: 3.006

9.  Clinical outcomes after transfusion-associated hepatitis C.

Authors:  M J Tong; N S el-Farra; A R Reikes; R L Co
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

10.  Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile.

Authors:  G L Davis; L A Balart; E R Schiff; K Lindsay; H C Bodenheimer; R P Perrillo; W Carey; I M Jacobson; J Payne; J L Dienstag
Journal:  Clin Ther       Date:  1994 Mar-Apr       Impact factor: 3.393

View more
  18 in total

Review 1.  Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies.

Authors:  John B Wong
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study.

Authors:  T Piche; G Vanbiervliet; F Cherikh; Z Antoun; P M Huet; E Gelsi; J-F Demarquay; F-X Caroli-Bosc; S Benzaken; M-C Rigault; C Renou; P Rampal; A Tran
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

Review 3.  Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens.

Authors:  Umberto Vespasiani-Gentilucci; Giovanni Galati; Paolo Gallo; Antonio De Vincentis; Elisabetta Riva; Antonio Picardi
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

4.  Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study.

Authors:  Souvik Sarkar; Zhen Jiang; Donna M Evon; Abdus S Wahed; Jay H Hoofnagle
Journal:  J Hepatol       Date:  2012-07-01       Impact factor: 25.083

Review 5.  Fatigue complicating chronic liver disease.

Authors:  E Anthony Jones
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 6.  Hepatitis C virus infection and the brain.

Authors:  Karin Weissenborn; Anita B Tryc; Meike Heeren; Hans Worthmann; Henning Pflugrad; Georg Berding; Martin Bokemeyer; Hans L Tillmann; Annemarie Goldbecker
Journal:  Metab Brain Dis       Date:  2009-01-07       Impact factor: 3.584

Review 7.  Hepatitis C Virus Infection in the Older Patient.

Authors:  Michael Reid; Jennifer C Price; Phyllis C Tien
Journal:  Infect Dis Clin North Am       Date:  2017-12       Impact factor: 5.982

8.  Reduced cerebral cortical thickness in Non-cirrhotic patients with hepatitis C.

Authors:  Simon Hjerrild; Signe Groth Renvillard; Peter Leutscher; Leif Hougaard Sørensen; Leif Østergaard; Simon Fristed Eskildsen; Poul Videbech
Journal:  Metab Brain Dis       Date:  2015-11-03       Impact factor: 3.584

9.  Biopsychosocial predictors of fatigue in quiescent and mild ulcerative colitis - an explorative study.

Authors:  Winfried Häuser; Andreas Stallmach; Rueya-Daniela Kocalevent; Matthias Rose; Herbert Fliege
Journal:  Psychosoc Med       Date:  2005-06-27

10.  Socio-demographic and clinical features of Irish iatrogenic hepatitis C patients: a cross-sectional survey.

Authors:  Olivia McKenna; Caitriona Cunningham; Catherine Blake
Journal:  BMC Public Health       Date:  2009-09-07       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.